The 17 references in paper O. Sirotkina V., N. Bogan’kova A., A. Laskovets B., G. Kuharchik A., L. Gaykovaya B., T. Vavilova V., О. Сироткина В., Н. Боганькова А., А. Ласковец Б., Г. Кухарчик А., Л. Гайковая Б., Т. Вавилова В. (2014) “ИММУНОЛОГИЧЕСКИЕ МЕТОДЫ В ОЦЕНКЕ ФУНКЦИОНАЛЬНОЙ АКТИВНОСТИ ТРОМБОЦИТОВ У БОЛЬНЫХ С СЕРДЕЧНО-СОСУДИСТЫМИ ЗАБОЛЕВАНИЯМИ // IMMUNOLOGICAL METHODS FOR EVALUATION OF PLATELET FUNCTIONS IN THE PATIENTS WITH CARDIOVASCULAR DISEASES” / spz:neicon:mimmun:y:2010:i:3:p:213-218

1
Хайдуков С.В., Зурочка А.В. Вопросы современной проточной цитометрии. Клиническое применение. – Челябинск, 2008. – 195 с.
(check this in PDF content)
2
Шитикова А.С. Тромбоцитарный гемостаз. – СПб.: Издательство СПб ГМУ, 2000. – 227 с.
(check this in PDF content)
3
Barsky A.A., Arora R.R. Clopidogrel resistance: myth or reality? // J. Cardiovasc. Pharmacol. Therapeut. – 2006. – Vol. 11, N 1. – P. 47-53.
(check this in PDF content)
4
Braun O.O., Amisten S., Wihlborg A.-K., Hunting K., Nillson D., Erlinge D. Residual platelet ADP reactivity after clopidogrel treatment is dependent on activation of both the unblocked P2Y1 and the P2Y12 receptor and is correlated with protein expression of P2Y12 // Purinergic Signalling. – 2007. – Vol. 3. – P. 195-201.
(check this in PDF content)
5
Braun O.O., Johnell M., Varenhorst C., James S., Brandt J.T., Jakubowski J.A., Winters K.J., Wallentin L., Erlinge D., Siegbahn A. Greater reduction of platelet activation markers and plateletmonocyte aggregates by prasugrel compared to clopidogrel in stable coronary artery disease // Thromb. Haemost. – 2008. – Vol. 100, N 4. – P. 626-633.
(check this in PDF content)
6
Cattaneo M. Resistance to antiplatelet drugs: molecular mechanisms and laboratory detection // J. Thromb. Haemost. – 2007. – Vol. 5, N 1. – P. 230-237.
(check this in PDF content)
7
Еnjeti A.K., Lincz L.F., Seldon M. Detection and measurement of microparticles: an evolving research tool for vascular biology // Semin Thromb Hemost. – 2007. – Vol. 33. – N 8. – P. 771-779.
(check this in PDF content)
8
Ferguson A., Dokainish H., Lakkis N. Aspirin and clopidogrel response variability // Tex. Heart. Inst. J. – 2008. – Vol. 35, N 3. – P. 313-320.
(check this in PDF content)
9
Fitzgerald D.J., Maree A. Aspirin and clopidogrel resistance // Hematology. Am. Soc. Hematol. Educ. Program. – 2007. – P. 114-120.
(check this in PDF content)
10
Gurbel P.A., Tantry U.S. Clopidogrel resistance? // Thromb. Research. – 2007. – Vol. 120. – P. 311-321.
(check this in PDF content)
11
Hayward C.P.M. Advances in understanding «high on-treatment platelet reactivity» // Thromb. Haemost. – 2009. – Vol. 102. – P. 799-800.
(check this in PDF content)
12
ISLH 2008, Sydney, Coagulation / Haemostasis Workshop.
(check this in PDF content)
13
Koenig W. Haemostatic risk factors for cardiovascular diseases // Eur. Heart. J. – 1998. – Vol. 19. – C. 39-43.
(check this in PDF content)
14
Oestreich J., Smyth S., Campbell C. Platelet function analisis: at the edge of meaning // Thromb. Haemost. – 2009. – Vol. 101. – P. 217-219.
(check this in PDF content)
15
Shantsila E., Lip G.Y.H. The role of monocytes in thrombotic disorders // Thromb. Haemost. – 2009. – Vol. 102. – P. 916-924.
(check this in PDF content)
16
Storey R., JudgeH., Heptinstall S. Inhibition of ADP-induced P-selectin expression and plateletleukocyte conjugate formation by clopidogrel and the P2Y12 receptor antagonist AR-C69931MX but not aspirin // Thromb. Haemost. – 2002. – Vol. 88, N 3. – P. 488-494.
(check this in PDF content)
17
Szczeklik A., Musial J., Undas A., Sanak M. Aspirin resistance // J. Thromb. Haemost. – 2005. – Vol. 3. – P. 1655-1662. поступила в редакцию 22.12.2009 отправлена на доработку 11.01.2010
(check this in PDF content)